LPL and hyperlipidemia: Similarly, another study by Na et al. [15] showed that in overweight patients with hyperlipidemia, participants receiving mangiferin exhibited reduced serum TG and free fatty acid (FFA) levels and insulin resistance index, while plasma HDL-C levels and lipoprotein lipase (LPL) activity were increased.